Navigation Links
HCM Announces Substantial Growth in 2007
Date:2/26/2008

Attracts new talent to key positions

BURLINGTON, Mass., Feb. 26 /PRNewswire/ -- Hyaluron Contract Manufacturing (HCM), a leading provider of pharmaceutical development services, continued to expand its business in 2007 with revenues increasing greater than 75 percent and staffing increasing greater than 60 percent to support past and anticipated future growth. Additionally, HCM acquired additional space at its Burlington MA facility to expand its analytical chemistry, microbiology and engineering laboratories as well as to provide additional manufacturing capacity.

"We are very proud of our recent growth," Shawn Kinney, president of HCM states. "It's a reflection of our ongoing commitment to continuous improvements and to providing high quality products and services to our customers."

HCM has continued to strengthen its management team with the appointment of Susan McNamara to the newly created position of Director of Quality and Christopher Paolillo to the position of Director of Contract Administration and Legal Affairs and other key hires.

Susan McNamara has over seventeen years of experience in the biotechnology industry, bringing novel recombinant proteins into clinical and commercial production. Before joining HCM, McNamara was Associate Director, QC Microbiology at Wyeth Biotech. Prior to that, McNamara was employed by Fisons Pharmaceuticals and SmithKline.

Christopher Paolillo has over twenty-seven years of experience as corporate counsel and as an attorney in private practice and with the office of Air Force Judge Advocate. He brings to HCM substantial experience in contracts, licensing, intellectual property, and commercial transactions. Prior to HCM, Paolillo was employed by ACI Worldwide (formerly P&H Solutions) as Vice President and Corporate Counsel.

Located in Burlington, MA, HCM has been offering aseptic formulation and filling services to biotechnology and pharmaceutical companies. At the core of HCM's business is a commitment to quality, regulatory compliance and on-time delivery.
For further information, visit http://www.hyaluron.com

Contact: Claudio Tracanna

Office Phone: 781-270-7900 x 114

Cell Phone: 781-443-2850

Email: ctracanna@hyaluron.com


'/>"/>
SOURCE Hyaluron, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NPS Pharmaceuticals Announces Senior Management Changes
2. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
3. Boston Scientific Announces Addition to Clinical Sciences Organization
4. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
7. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
8. Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
9. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
10. Aton Pharma Announces the Appointment of Dr. Fred Eshelman to Management Board
11. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... 2017  BioTech Holdings announced today identification and ... ProCell stem cell therapy prevents limb loss in ... demonstrated that treatment with ProCell resulted in more ... compared to standard bone marrow stem cell administration.  ... reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):